Moderna Inc (MRNA)

416.26
-2.79(-0.67%)
After Hours
421.20
+4.94(+1.19%)
- Real-time Data
  • Volume:
    25,491,424
  • Bid/Ask:
    421.20/421.99
  • Day's Range:
    403.00 - 443.99

MRNA Overview

Prev. Close
419.05
Day's Range
403-443.99
Revenue
2.73B
Open
409.72
52 wk Range
54.3-443.99
EPS
1.25
Volume
25,491,424
Market Cap
168.26B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
13,369,600
P/E Ratio
334.13
Beta
-
1-Year Change
434.09%
Shares Outstanding
401,527,789
Next Earnings Date
Aug 05, 2021
What is your sentiment on Moderna Inc?
or
Market is currently closed. Voting is open during market hours.

Moderna Inc News

Moderna Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyStrong BuyStrong Buy
Technical IndicatorsNeutralStrong BuyStrong BuyStrong BuyBuy
SummaryBuyStrong BuyStrong BuyStrong BuyStrong Buy

Moderna Inc Company Profile

Moderna Inc Company Profile

Employees
1300

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group for fill-finish manufacturing of its COVID-19 vaccine candidate, as well as Aldevron, LLC for supporting COVID-19 vaccine and additional programs in company’s clinical development pipeline. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Read More
  • 600 buy next week..
    1
    • 450 soon🍾
      1
      • fda approval soon
        1
        • buy 6000% beat. boosters to come... sold out for fy21. monopoly, cancer drug
          1
          • Buy SONM 💎🚀
            0
            • This stock has already extrem growth priced in, would be surprised if there is a lot of upward potential. I cashed in - no regret - I think there are better growth stocks to play covid at this stage...
              1
              • Game Stop Reloaded
                1
                • the issue with this stock is that there was never a consolidation or correction. It is long overdue and will be coming. Consolidation has started.No stock should behave like this.
                  1
                  • This stock was 20 usd January last year, see how far it come now. It will continue few more years atleast..
                    4
                    • 1000 bud
                      0
                  • om the long term side, i totall agree to see this stock around 500 usd end of 2021 but not now…
                    7
                    • seems that I am stepping on someones toes - 5 dislikes?? rly?
                      1
                  • Most of us have heard things like, "this will fall to 90$ at 150$". Or "this will fall to 200$ at 300$". And some of us understand the power of short-term Long-term long-term investing rather than short term. This company will continue to grow. Long term investing always stands superior.
                    3
                    • Based on the incredible results and continued global demand for this vaccine, as well as, upcoming FDA Approval, smart investors know this will easily surge to 500 and beyond. Strong Buy today.
                      5
                      • HODL!!!🔜500.00 and 🚀🚀🚀🚀🚀🚀🚀
                        4
                        • soon mRNA will be faced with the truth....it never worked just is an abused hype covered by political systems and enforced.Ask or better research for the animal testing results....
                          1
                        • you said it bro
                          0
                      • Buy SONM 💎
                        4
                        • 360 is 2 low for ya?? I guess thats the minimum line it will drop to. I could also expect 320 or even 270 to close the gap :)
                          9
                          • its not gonna make it better if u only vote me down :)
                            4
                        • Take the profit and wait for 300 to enter again
                          8
                          • why not short to get quicker to 300
                            0
                        • TP sell of??
                          1
                          • Bubble stocks act like this... just a tip...
                            3
                            • Will buy at 320.
                              5
                              • i see this stock to be at 360 at least
                                9
                                • no need to wait till eod for red
                                  0
                                  • if you buy this over $400 don't cry later
                                    4
                                    • A fair price is 80. Not 425. Total stock market is a bubble.
                                      6
                                      • another short ooened at 440. lets see
                                        1
                                        • When vaccin only provide 1 year protection, price should drop to 20%.
                                          1
                                          • ? rtrded
                                            0
                                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.